Oppenheimer Asset Management Inc. Ideaya Biosciences, Inc. Transaction History
Oppenheimer Asset Management Inc.
- $8.4 Billion
- Q2 2025
A detailed history of Oppenheimer Asset Management Inc. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 13,787 shares of IDYA stock, worth $420,641. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,787
Previous 11,560
19.26%
Holding current value
$420,641
Previous $189,000
52.91%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IDYA
# of Institutions
222Shares Held
83.5MCall Options Held
28.7KPut Options Held
132K-
Black Rock Inc. New York, NY6.81MShares$208 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.55MShares$200 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X06.21MShares$189 Million0.07% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.03MShares$153 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.94MShares$151 Million0.0% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.47B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...